DentalCare Logo

The Intraoral and Extraoral Exam

Course Number: 337

Background

In 2024, an estimated 396,937 People were living with oral cavity cancer in the United States. The National Cancer Institute (SEER) 2024 reports an estimate of new cases of oral cavity and pharyngeal cancers to be 54,450 which is 2% of all new cancer cases. This amounts to 12,230 of estimated deaths and 2% of all cancer deaths. SEER data suggests that 64.8% of patients will survive more than 5 years. Men are two times more likely to develop oral cancer. The average age or risk factor is 66 and over — with only 20% under 55 years old. White males are more likely to develop cancer followed by black males and Hispanic males. The tongue is the most prominent area followed by the tonsils, oropharynx, gums and floor of the mouth.1,3

Cancer of the Lung and bronchus is responsible for most full-body cancer deaths with 131,880 people expected to die from these cancers. Colon and rectal cancer is the second most commonly occurring cancer. The oral exam is extremely important in early oral cancer detection, but it is also invaluable in detecting other cancers that may occur elsewhere in the body and may also exhibit signs within the oral tissues. Estimates of new cancers in 2024 from the National Cancer Institute is 2, 001,140 with an estimated death of 611,720. The five -year survival rate is 69%. 39.3 % men and women will be diagnosed with cancer during their lifetime. Very similar data is reported from the American Cancer Society for 2025: 2,041,910 new cancer cases with 618,120 cancer deaths in the United States.6

The increase in incidence of oropharyngeal cancer in white males is due to an increase in cancers at the base of the tongue and tonsils associated with human papillomavirus (HPV) infections.1 It is expected that the rate of HPV infections for both male and females will decrease in the future with the new vaccines that are available currently. Head and neck cancers rank 8th in cancers worldwide with an annual incidence rate of 600,000 individuals.46 Studies have shown that visual and tactile examination of the structures of the head, neck and oral cavity are effective in detecting abnormalities occurring within these structures. Therefore, procedures such as the head and neck and intraoral examinations, often referred to as an oral cancer examination or oral cancer screening, are important elements of a complete patient assessment. These examinations should be performed on a routine basis who presents for a yearly dental exam, not just new patients or those with known risk factors such as the use of tobacco or alcohol, increasing age, or + HPV status.

Current SEER data indicates that over the last ten years, cancer rates in general have decreased. This is attributed to new testing technology, patient awareness, early intervention and a focus on life-style interventions. Only 5% of cancers are due to hereditary factors.2 Cancers detected at Stage 1 or Stage 2 have an 80% chance of being cured, cancer detected at Stage 3 or 4 have an 80% chance that you will not like the outcome. When detected early, the survival rate is 90%; but sadly 80% of cancer is detected late and at stage 3 or 4. There is also a cost benefit to early detection. A late-stage renal cancer treatment can run into the millions of dollars. If an early diagnosis had been found, the person would have paid about 10,000 dollars for a surgical intervention with a positive outcome. Another example is colorectal cancer that is localized at state 1, has a five-year survival rate of almost 100% but when it has spread, the rate is 14%. Early detection and treatment normally results in less surgery, less radiation and chemotherapy, and a better quality of life for the patient long-term. Treatment for oral, oropharyngeal and other head and neck cancers diagnosed at later stages is usually associated with more extensive dysfunction and disfigurement than treatment for those same cancers diagnosed in earlier stages. Complications associated with therapy for oral, oropharyngeal and other head and neck cancers include: altered eating and swallowing patterns, salivary gland dysfunction (often total loss of the salivary glands), and loss of hard and soft oral tissues such as teeth, bone, and parts of the tongue, among others. Recent SEER data reports an increase in detection of cancers in the posterior tongue region (Oral Pharyngeal Cancer). The estimate for new United States cases of oral cancer in 2024 is 54,450 with 12,230 deaths. This represents 2.9% of all cancer deaths. With more knowledge by dental professionals, more cancers are being identified and treated early.3

In a 2010 study, Rethman et al. reported there was sufficient evidence-based information to support oral cancer screening by visual and tactile methods as a means to detect cancer in the early stages.4 The report further stated that adjunctive screening devices were no more effective in early detection than a thorough visual and tactile exam. In 2009 Watson et al. looked at a group of patients already diagnosed with oral or pharyngeal cancer to determine if oral/pharyngeal cancer screening examinations conducted in the general dental office were associated with early detection. The researchers found those patients who had a screening examination within the last year were significantly more likely to have an early stage cancer than those who did not have the examination.4 Oral exams and screenings continue to be an intricate part of the dental appointment. Recent studies conducted by the US Preventive Services Task Force evaluated the screening and preventive interventions for oral health in children and adolescents aged 5 to 17 years old. The researchers concluded insufficient evidence (assigning an “I” statement score) exists to assess the balance of benefits and harms of routine screening for oral health conditions when performed by primary care clinicians in asymptomatic children and adolescents in this age group. They suggest that further research should be conducted.5

Some screenings in years past, have been performed by non-dental or medical providers. Recently in 2020, Otolaryngologists have reported screening of the oral tissues and oropharyngeal areas within community screenings. The screening of 285 patients resulted in referrals to dental, ENT and Primary Physician follow ups. They suggested opportunities for collaborative efforts with other professions.7 This is especially important because of the involvement of HPV in increased oral cancer cases. The ACS and the American Dental Association among others continue to recommend oral cancer examinations as a vital element of routine dental examinations.8,9

The length of time between a patient’s initial consultation with a healthcare provider and a diagnosis of cancer is termed “professional delay.”10 Professional delay may be caused by inadequate clinical skills and knowledge, a low threshold of suspicion, lack of experience, and the presence of non-specific signs/symptoms. Studies by Yu found a delay of as much as 6 months, much longer than expected, from the time of the initial examination to the diagnosis/treatment.11 In addition to professional delay, patients may delay seeking care themselves for many reasons. A study by Zhang, et al. 2019 listed males, farmers and current smokers as most likely to delay seeing a dental professional. Some common reasons listed for patient delay in seeking treatment are: lack of knowledge of the signs and symptoms of oral cancer leading to a low level of suspicion, no pain, and fear of the dentist.12,13 Cancer progression is relatively rapid in the oral tissues, and as one would expect, professional and or patient delay results in more late stage diagnoses, more extensive surgery and more radiation and chemotherapy for the patient.

A complete head/neck and intraoral examination is not only important for the early detection of cancer but also for accomplishing a comprehensive assessment of the patient prior to providing dental treatment (Table 1).

Box I. Best management practices for the disposal of mercury-containing scrap amalgam.19,20

  • Stock pre-capsulated amalgam alloys in a variety of sizes instead of bulk elemental mercury to minimize the amount of hazardous mercury-containing amalgam waste generated.
  • Collect and store used disposable amalgam capsules in a wide-mouthed, airtight container labeled “Hazardous Waste - Amalgam Capsules.”
    • Once the container is full, have an approved hazardous waste transporter deliver it to an approved hazardous waste management facility.
    • DO NOT PLACE AMALGAM CAPSULES IN NON-HAZARDOUS OFFICE WASTE OR REGULATED MEDICAL WASTE CONTAINERS.
  • Use chairside disposable or reusable traps, vacuum pump filters and an ISO 11143-compliant amalgam separator to capture amalgam particles generated when removing old or carving new amalgam restorations.
    • Chairside trap – when the trap is full, remove trap according to manufacturer’s recommendations. If reusable, clean according to manufacturer’s recommendations. Place contents and any disposable traps in a wide-mouthed, airtight container labeled “Hazardous Waste – Scrap Amalgam.”
    • Once the container is full, have an approved hazardous waste transporter deliver it to an approved hazardous waste management facility. a. DO NOT RINSE DISPOSABLE CHAIRSIDE TRAPS THAT CONTAIN AMALGAM PARTICLES IN THE SINK. b. DO NOT TROW DISPOSABLE CHAIRSIDE TRAPS THAT CONTAIN AMALGAM PARTICLES IN NON-HAZARDOUS OFFICE WASTE OR REGULATED MEDICAL WASTE CONTAINERS.
    • Vacuum pump filter – change filter according to manufacturer’s recommendations, put the lid on the filter and place it in the box in which it was originally shipped. Once the box is full, have an approved hazardous waste transporter deliver it to an approved hazardous waste management facility.
      • DO NOT RINSE VACUUM PUMP FILTERS THAT CONTAIN AMALGAM PARTICLES IN THE SINK.
      • DO NOT TROW DISPOSABLE VACUUM PUMP FILTERS THAT CONTAIN AMALGAM IN NON-HAZARDOUS OFFICE WASTE OR REGULATED MEDICAL WASTE CONTAINERS.
    • Amalgam separators -- Follow manufacturer’s recommendations for maintenance and recycling procedures.

The head and neck examination is often overlooked by busy clinicians, but it is as crucial an element of the total cancer examination. A thorough head and neck examination is essential for detecting early skin cancers and enlarged lymph nodes that may indicate cancer metastasis. In addition to cancer, manifestations of systemic disease may be observed during routine dental and oral cancer examinations. With the baby boomers in retirement age, the number of patients with chronic disease continues to increase. By 2040 about 22% of all Americans, more than 82 million people, will be older than 65 years old.15 The knowledgeable dental professional will be able to identify suspicious manifestations and arrange the appropriate referral for evaluation, and follow-up. Although oral cancer is a disease associated with aging, we have seen a continuing increase of oral cancer diagnoses in patients under age 40 with no known risk factors; HPV 16 included in this age group is a significant increase in cancer of the tongue.17 Current research implicates the human papillomavirus (HPV) as the underlying cause of as many as 72 percent of oropharyngeal squamous cell carcinomas with a predominate increase seen in younger white men.18 Persistent HPV infections are the leading cause of oral pharyngeal cancers, specifically HPV 16 and 18 that are classified as high oncogenic/high risk types.43 Practitioners who focus on patients at high risk may miss subtle changes in those patients who have no known risk factors or those who do not fit the perceived profile of oral cancer susceptibility such as those who have not smoked or consumed alcohol. With increases of oral cancer in younger age groups, all patients, regardless of age or presence of risk factors, should be examined for oral cancer. In general, cancer in younger populations tends to be much more aggressive and have a poorer prognosis.27 In a study by Rowan, et al. 2015, participants consisting of dental hygienists and dentists reported that only 73% of respondents included the oropharynx in their oral exam. Less than 50% reported the correct location for the greatest increase in cancer with 40% of all groups indicating that a biopsy from the posterior oropharynx should be tested for HPV.42 The authors recommend continued education on HPV and oral cancer. In an educational intervention by Shukla et al. 2018, the authors provided a toolkit and a post intervention survey. The researchers concluded that over 91.6% of participants increased their knowledge about HPV. They concluded that the educational process gave participants an opportunity to talk to their patients about HPV and also the HPV vaccination and prevention of the virus.42 There is also a rise in thyroid cancer with an estimated 2,170 deaths in 2024. This is 2.2% of all new cancer cases. The total number of new cases is 44,020 according to the National Cancer Institute. The thyroid exam is an integral part of the total oral cancer examination.42

The purpose of this course is multifold:

  1. to introduce the protocol for a complete oral cancer examination with proper techniques for both the head and neck and intraoral examinations,

  2. to provide patient education information,

  3. to provide information on adjunct technologies that may be utilized in lesion detection and,

  4. to promote informing all patients that they are receiving a complete oral cancer examination.